A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case
Current Oncology · 2023
DOI: 10.3390/curroncol30100649 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Valérie Larouche und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hemato-oncology, Centre Hospitalier Universitaire de Quebec-Université Laval, Quebec, QC G1V4G2, Canada. Hauptthemen laut MEDLINE: Congenital Microtia, Mastocytosis, Systemic, Mastocytosis, Mastocytosis, Cutaneous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mastocytosis is a heterogeneous group of rare hematological disorders that can occur in infancy. We report a 16-year-old girl who presented with an aggressive form of systemic congenital mastocytosis, associated with a significant global developmental delay, deafness, and multiple anomalies. At 4 years of age, she developed a germinoma presenting as an invasive spinal mass. Extensive cytogenetic, metabolic, and molecular genetic studies that included whole-exome sequencing studies revealed a KIT alteration (NM_000222.3(KIT):c2447A > 7 pAsp816Val) and likely pathogenic variant in the DNA from peripheral blood and skin lesions. C-kit was also found to be overexpressed in the spinal tumor cells. We compared the features of this child to those of six previously reported pediatric patients with cutaneous mastocytosis, microcephaly, microtia, and/or hearing loss reported in OMIM as mastocytosis, conductive hearing loss, and microtia (MIM 248910), for which the etiology has not yet been determined. This report extends the currently recognized spectrum of KIT-related disorders and provides clues as to the potential etiology of a syndromic form of congenital mastocytosis. International efforts to understand the benefits of long-term targeted therapy with tyrosine kinase inhibitors for this KIT-altered rare disease should continue to be evaluated in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hemato-oncology, Centre Hospitalier Universitaire de Quebec-Université Laval, Quebec, QC G1V4G2, Canada.
- Medecine Faculty, Laval University, Quebec, QC G1V4G2, Canada.
- Department of Dermatology, Centre Hospitalier Universitaire de Quebec-Université Laval, Quebec, QC G1V4G2, Canada.
- Departement of Pediatric, Centre Hospitalier Universitaire de Quebec-Université Laval, Quebec, QC G1V4G2, Canada.
- Department of Pathology, Centre Hospitalier Universitaire de Quebec-Université Laval, Quebec, QC G1V4G2, Canada.
- Department of Medical Genetics, Centre Hospitalier Universitaire de Quebec-Université Laval, Quebec, QC G1V4G2, Canada.
ORCID-Profile: Valérie Larouche, Nada Jabado, Isabelle De Bie
Zitieren
APA
Larouche, V., Paré, M. F., Grenier, P. O., Wieckowska, A., Gagné, E., Laframboise, R., Jabado, N., & De Bie, I. (2023). A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case. Current Oncology. https://doi.org/10.3390/curroncol30100649
Vancouver
Larouche V, Paré MF, Grenier PO, Wieckowska A, Gagné E, Laframboise R, et al. A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case. Current Oncology. 2023. doi:10.3390/curroncol30100649
BibTeX
@article{Larouche2023,
author = {Larouche, Valérie and Paré, Marie-Frédérique and Grenier, Pierre-Olivier and Wieckowska, Anna and Gagné, Eric and Laframboise, Rachel and Jabado, Nada and De Bie, Isabelle},
title = {A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30100649}
}
EUVIMED